Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Wed 22 Feb 2023, 8:00 CORONATION FUND MANAGERS LIMITED - Update To Shareholders: Next Steps In SARS Litigation, Financial Impact And Withdrawal Of Cautionary Announcement
Update To Shareholders: Next Steps In SARS Litigation, Financial Impact And Withdrawal Of Cautionary Announcement

CORONATION FUND MANAGERS LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 1973/009318/06
Share code: CML
ISIN: ZAE000047353
LEI: 3789001BC9A29E6FF77
(“Coronation” or “the Company”)


UPDATE TO SHAREHOLDERS: NEXT STEPS IN SARS LITIGATION, FINANCIAL IMPACT
AND WITHDRAWAL OF CAUTIONARY ANNOUNCEMENT


Shareholders are referred to the cautionary announcement released on SENS by the
Company on 8 February 2023 (“previous announcement”).

Shareholders were informed in the previous announcement of the outcome of the Supreme
Court of Appeal (“SCA”) hearing in the matter of South African Revenue Service (“SARS”) vs
the Company’s subsidiary, Coronation Investment Management SA (Pty) Ltd (“CIMSA”).

As conveyed in the previous announcement, the Company is disappointed with the SCA
judgment in favour of SARS, which overturned the decision of the Western Cape Tax Court.


Next steps in the SARS Litigation

After careful consideration, the boards of the Company and CIMSA, informed by the advice of
legal counsel and professional tax advisers, have determined that CIMSA should apply to the
Constitutional Court for leave to appeal against the SCA judgment and such application will
be made within the stipulated timeline. 


Financial impact

Notwithstanding the decision to apply for leave to appeal, the Company is required to raise a
provision as a consequence of the SCA judgement.

The provision is based on all financial years from 2012 to 2022 being impacted by the
application of the SCA judgment and is estimated to be between R800 million and R900
million.

Shareholders are advised that the expected impact of the provision will reduce earnings per
share (“EPS”), headline earnings per share (“HEPS”) and diluted headline earnings per share
(“DHEPS”) for the six months ended 31 March 2023 when compared to the EPS, HEPS and
DHEPS for the six months ended 31 March 2022. Due to the material financial impact, the
Company will not be paying an interim dividend for the period ended 31 March 2023.

Shareholders are advised that this is not a trading statement in terms of the JSE Listings
Requirements, as the Company is not in a position where it has a reasonable degree of
certainty regarding the expected range for EPS, HEPS and DHEPS for the six months ended
31 March 2023.

The financial information on which this SENS has been based has not been reviewed nor
reported on by the Company’s external auditors.


Withdrawal of the Cautionary Announcement contained in the previous SENS

As a result of the detailed disclosure contained in this announcement, Shareholders are
advised that the cautionary contained in the previous SENS is hereby withdrawn. Caution is,
therefore, no longer required to be exercised when dealing in the Company’s securities.



Cape Town
22 February 2023

Sponsor
PSG Capital  

Date: 22-02-2023 08:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData


Follow us on: